Udo Bauer is an accomplished pharmaceutical research and development executive with nearly three decades of experience in drug discovery and development. He currently serves as a consultant and board member to Biotechs in the northern countries of Europe. Previously worked as a Competitive Intelligence Director for Early R&D CVRM at AstraZeneca, he brings extensive expertise in medicinal chemistry and drug development, particularly in cardiovascular, renal, and metabolic diseases. His career encompasses roles in scientific program direction, search and evaluation, and strategic innovation at AstraZeneca, as well as research experience at FibroGen Inc.

A Ph.D. graduate in Organic Chemistry from FAU Erlangen-Nürnberg, Udo combines deep scientific knowledge with strategic business acumen to drive pharmaceutical innovation and development. He currently serves as a Board Member at Emeriti Bio, further expanding his influence in the biotechnology sector.